JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 12.36% |
| 3 | Healthcare | 9.31% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACOR
3326
DELISTED
Acorda Therapeutics
ACOR
| $1.78M | ﹤0.01% |
2,004
-19
| -0.9% | -$23.3K |
|
3327
Scansource
SCSC
$1.08B
| $1.77M | ﹤0.01% |
54,641
-2,980
| -5% | -$101K |
|
3328
PUT
Trupanion
TRUP
$1.34B
| $1.77M | ﹤0.01% |
+50,800
| New | +$1.67M |
|
|
CNCE
3329
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.77M | ﹤0.01% |
150,592
+2,097
| +1% | +$22.6K |
|
|
SGI
3330
Somnigroup International
SGI
$13.9B
| $1.76M | ﹤0.01% |
97,600
+13,292
| +16% | +$214K |
|
|
VIAB
3331
PUT
DELISTED
Viacom Inc. Class B
VIAB
| $1.76M | ﹤0.01% |
60,000
-294,800
| -83% | -$8.62M |
|
3332
Sunoco
SUN
$14.2B
| $1.75M | ﹤0.01% |
55,835
-98,597
| -64% | -$3.03M |
|
3333
Virtus Investment Partners
VRTS
$1.13B
| $1.75M | ﹤0.01% |
16,624
+10,943
| +193% | +$1.22M |
|
3334
Park National Corp
PRK
$3.75B
| $1.75M | ﹤0.01% |
17,778
+2,460
| +16% | +$239K |
|
3335
Zymeworks
ZYME
$1.78B
| $1.75M | ﹤0.01% |
79,296
+60,472
| +321% | +$1.11M |
|
|
BRY
3336
DELISTED
Berry Corp
BRY
| $1.73M | ﹤0.01% |
167,896
+28,529
| +20% | +$323K |
|
|
SDRL
3337
DELISTED
Seadrill Limited Common Stock
SDRL
| $1.73M | ﹤0.01% |
413,632
-624,739
| -60% | -$4.1M |
|
3338
Forrester Research
FORR
$217M
| $1.72M | ﹤0.01% |
36,464
+9,630
| +36% | +$464K |
|
3339
Mercantile Bank Corp
MBWM
$1.06B
| $1.72M | ﹤0.01% |
53,664
+4,610
| +9% | +$151K |
|
3340
Nordic American Tanker
NAT
$1.42B
| $1.72M | ﹤0.01% |
768,521
+579,347
| +306% | +$1.25M |
|
3341
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.17B
| $1.72M | ﹤0.01% |
34,172
+20,316
| +147% | +$1.01M |
|
3342
Diodes
DIOD
$4.77B
| $1.71M | ﹤0.01% |
48,567
-10,688
| -18% | -$378K |
|
3343
Baytex Energy
BTE
$3.06B
| $1.7M | ﹤0.01% |
1,105,415
+14,474
| +1% | +$26.3K |
|
3344
FS Bancorp
FSBW
$323M
| $1.7M | ﹤0.01% |
67,126
+44,702
| +199% | +$1.12M |
|
3345
Genesco
GCO
$391M
| $1.7M | ﹤0.01% |
40,056
+2,668
| +7% | +$118K |
|
3346
Gyre Therapeutics
GYRE
$708M
| $1.7M | ﹤0.01% |
29,565
-895
| -3% | -$55.9K |
|
|
GWPH
3347
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.69M | ﹤0.01% |
9,927
+5,826
| +142% | +$1.01M |
|
3348
Cleveland-Cliffs
CLF
$6.79B
| $1.69M | ﹤0.01% |
161,919
-103,606
| -39% | -$1.02M |
|
3349
Howard Hughes
HHH
$3.98B
| $1.68M | ﹤0.01% |
13,419
+959
| +8% | +$98.2K |
|
|
RST
3350
DELISTED
ROSETTA STONE INC
RST
| $1.68M | ﹤0.01% |
74,391
+4,206
| +6% | +$101K |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.